Ryan Travers represents clients in connection with a broad range of antitrust issues related to litigation, government investigations and mergers and acquisitions. He has worked for clients in a diverse range of industries, including technology, travel, telecommunications and pharmaceuticals.
Some of Mr. Travers’s recent experience includes representing:
- Sabre Corp. in a three-week jury trial victory in an action brought by US Airways alleging violations of Sections 1 and 2 of the Sherman Act;
- Sabre Corp. in connection with its acquisition of Farelogix, Inc., including a two-week bench trial victory in a lawsuit brought by the Department of Justice (DOJ);
- Actavis, Inc. and Teva Pharmaceuticals U.S., Inc. in litigation challenging patent settlement agreements; and
- a technology company in connection with a DOJ conspiracy investigation.
Mr. Travers also has represented clients before the Federal Trade Commission (FTC) and DOJ in numerous acquisitions, including Vertex Pharmaceuticals Inc. in its acquisition of ViaCyte, Inc., Visa Inc. in its acquisition of Plaid Inc., Embraer in a proposed joint venture with Boeing and NXP Semiconductors N.V. in its proposed acquisition by Qualcomm Inc.
Mr. Travers maintains a robust pro bono practice. He frequently represents clients in immigration proceedings and also has represented various amici curiae on briefs submitted to the U.S. Supreme Court and various U.S. Circuit Courts of Appeal regarding criminal justice issues. He also represented a criminal defendant before the Maryland Court of Appeals, filing briefs and presenting oral argument challenging the admission of artistic expression during criminal trial.